It is rare that a trial impact by one company improves its rival ‘s stock. Ascendis Pharma stock closed down 5 percent yesterday after the long-acting somatrogon growth hormone project of
Growth-hormone, also known as somatotropin, is just a pituitary hormone that secretion is regulated by hypothalamic neuro-hormones — somatostatin (inhibits) along with also somatoliberin